Patent 11906532 was granted and assigned to Haemonetics on February, 2024 by the United States Patent and Trademark Office.
Quality control formulations that do not require human donor-derived blood components for use in testing the efficacy of viscoelastic analysis reagents, and methods for preparing these formulations, are described.